Navigation Links
BASF Podcast: The Chemical Reporter - Why Does Caffeine Have a Stimulating Effect?
Date:5/13/2009

LUDWIGSHAFEN, Germany, May 13 /PRNewswire/ -- The very first thing many people do when they stumble out of bed in the morning is pour themselves a cup of coffee. The substance in the hot brew that helps wake you up is well-known all over the world: caffeine. Caffeine doesn't only come from coffee beans. Most of the caffeine is synthetically manufactured by the chemical industry. In entertaining episodes our Chemical Reporter answers questions of our Podcast listeners on Chemistry in our everyday life.

Direct subscription via RSS-Feed or iTunes (search for "basf"): http://corporate.basf.com/en/podcast/reporter.xml

    Podcast The Chemical Reporter, English edition:
   http://www.basf.com/podcast
    More podcasts:
    Podcast Chemistry of Innovations:http://www.basf.com/podcast

This podcast is the audible innovation magazine of BASF. Discover every month how Chemistry can help to shape our future. The actual episode is on "Lithium Ion Batteries - The Energy Store of the Future".

    RSS-subscription:http://corporate.basf.com/en/podcast/innovation.xml
    Direct subscription of BASF Podcasts via RSS-Feed
   http://corporate.basf.com/en/podcast/reporter.xml
   http://corporate.basf.com/en/podcast/innovation.xml

Direct iTunes subscription when iTunes is installed (or search for "basf"):

http://phobos.apple.com/WebObjects/MZSearch.woa/wa/search?s
'/>"/>

SOURCE BASF SE
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. BASF Podcast: The Chemical Reporter - Why do You Get Garlic Breath?
2. Chemical culprit in popcorn workers lung identified
3. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
4. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
5. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
6. Low Doses of Red Wine Chemical May Fight Diabetes
7. National Academies advisory: genes and toxic chemicals
8. Genomic technologies to identify toxic chemicals should be developed
9. Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria
10. American Chemical Societys Weekly Presspac -- Oct. 17, 2007
11. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 1KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 2KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 3KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 4KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 5KV Pharmaceutical Divests ANDA for Generic Version of Duac 28R 29 57754 6Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 1Merrimack Pharmaceuticals Names Clet Niyikiza Ph D Senior Vice President Development 14175 2Alzheimers Soars Global Focus Needed 3A Study 57748 1Alzheimers Soars Global Focus Needed 3A Study 57748 2Alzheimers Soars Global Focus Needed 3A Study 57748 3
Other Medicine Technology:Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 2Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 3Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 4Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 5Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin 6Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 2Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 3Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 4Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 5Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 6Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 7Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 8Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 9Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 10